Tony Lialin joined VivoSim as Chief Commercial Officer in August 2025. A 25+ year commercial leader in genomics, diagnostics, bioinformatics, and imaging, Tony has built global sales teams, closed transformative pharma partnerships, and delivered $10M+ in startup revenue leading to four acquisitions. At Illumina, he closed the company’s largest-ever $157M PO and managed a $403M portfolio across GRAIL, Natera, and AncestryDNA. Previously, he held senior roles at Invivoscribe as Chief Commercial Officer, Oxford Nanoimaging as VP Sales & Customer Success, Loop Genomics as Chief Commercial Officer, Illumina as Executive Strategic Account Manager, and Agilent Technologies. He will lead Sales, Marketing, Partnerships,and Customer Success at VivoSim. He holds a B.A. in Molecular, Cellular & Developmental Biology from the University of California, Santa Cruz.
